Myo-Inositol vs D-Chiro-Inositol: What Is the Difference?

Myo-inositol and D-chiro-inositol are two forms of inositol commonly found in supplements marketed for PCOS/PMOS. Both are involved in cellular signalling, including pathways related to insulin.

But are they interchangeable? And does taking them together in a 40:1 ratio guarantee better results?

Research suggests inositol may offer some benefits for PCOS/PMOS, but there is not enough high-quality evidence to establish one formulation as best for everyone.

How do myo-inositol and D-chiro-inositol differ?

Myo-inositol (MI) is the most abundant form of inositol in the body. It participates in several cellular processes, including insulin signalling and pathways involved in ovarian function.

D-chiro-inositol (DCI) is another form of inositol that also participates in insulin-related signalling. The body can convert myo-inositol into D-chiro-inositol through an enzyme-mediated process.

Researchers are investigating how these forms, individually and in combination, might influence metabolic and reproductive outcomes in people with PCOS/PMOS. However, their precise roles in the condition are not fully established, and neither form can be assumed to improve insulin sensitivity or ovulation in every person.

Why is the 40:1 ratio popular?

A 40:1 myo-inositol-to-D-chiro-inositol ratio is often promoted as the ideal balance for ovarian and metabolic health.

A 2019 study compared different inositol ratios in women with PCOS and reported favourable findings for the 40:1 combination. However, the study included only 56 participants across seven groups, leaving just eight participants per group.

That is a small evidence base for such a strong recommendation. The ratio used in a supplement also does not automatically reproduce the concentrations or balance of inositol inside different body tissues.

The 2023 international PCOS guideline concludes that evidence is insufficient to recommend a particular inositol type, dose or combination.

Claims that 40:1 is mandatory, that it guarantees ovulation, or that other ratios necessarily damage egg quality go beyond the available evidence.

What should you check before choosing a supplement?

• Read the full ingredient label. Check which forms of inositol are included and how much of each the product provides.
• Be cautious with universal dosing claims. A studied formulation is not automatically the right dose for every person.
• Consider your individual goal. Irregular cycles, metabolic health and fertility concerns may require different assessments and treatment options.
• Ask about interactions and suitability. A healthcare professional can help you assess whether a supplement makes sense alongside your existing care.

Your HeyTimi action

Before choosing an inositol product, write down the outcome you hope to improve and discuss it with your healthcare professional. If you decide to use a supplement, record your intake alongside relevant changes in your existing symptom and cycle logs.

These records can help you discuss your experience at follow-up appointments, but they cannot confirm ovulation, measure insulin resistance or prove that a supplement caused a change.

The takeaway: Myo-inositol and D-chiro-inositol are both biologically relevant, but the best combination for PCOS/PMOS has not been established. Treat the 40:1 ratio as a studied option, not a universal prescription.

Explore HeyTimi on the App Store

Medical sources

1. Nordio M, Basciani S, Camajani E. (2019). The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios.
2. Unfer V, et al. (2020). Inositols in PCOS.
3. Teede HJ, et al. (2023). Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.

Medical disclaimer: This lesson is for educational purposes only and is not intended to diagnose, treat, cure or prevent any medical condition. Consult a qualified healthcare professional before starting supplements or changing prescribed treatment.